Cardiol J. 2007;14(4):396-401.
We sought to investigate the profile of symptoms and results of investigations among six cases of suspected arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D).
The diagnosis of ARVC/D was made on the basis of standardised diagnostic criteria proposed by the study group on ARVC/D of the European Society of Cardiology. A study was conducted involving six patients with suspected ARVC/D that were diagnosed and treated at our centre in the years 1992-2004.
All patients presented with a typical history and with similar complaints and symptoms: limitation of exercise toleration, palpitations, dizziness, presyncope and syncope. In all six cases ECG abnormalities were detected, namely T wave inversion, prolonged QRS complexes in V1-V3 or/and epsilon waves. Echocardiographic abnormalities were also detected in all cases in the form of global or segmental dilation and a reduction in right ventricular ejection fraction, morphological irregularity of the endocardium and tricuspidal valve insufficiency. On the basis of diagnostic criteria we diagnosed ARVC/D in four cases and the borderline variant of ARVC/D in the remaining two.
ARVC/D is a heart muscle disease with varied and complex presentation. The profile of symptoms and the results of investigations and diagnostic procedures are varied and can assume various combinations. Accurate diagnosis can be established in most cases as a result of the non-invasive and widely-used techniques of ECG, 24-hour Holter monitoring and echocardiography. (Cardiol J 2007; 14: 396-401).
我们旨在研究六例疑似致心律失常性右室心肌病/发育不良(ARVC/D)患者的症状特征和检查结果。
ARVC/D 的诊断基于欧洲心脏病学会 ARVC/D 研究小组提出的标准诊断标准。我们对 1992 年至 2004 年在我们中心诊断和治疗的六例疑似 ARVC/D 患者进行了研究。
所有患者均有典型的病史和类似的主诉和症状:运动耐量受限、心悸、头晕、晕厥前和晕厥。在所有六例患者中均检测到心电图异常,即 T 波倒置、V1-V3 导联 QRS 波群延长和/或ε波。在所有六例患者中均检测到超声心动图异常,表现为全心或节段性扩张和右心室射血分数降低、心内膜和三尖瓣形态不规则及功能不全。根据诊断标准,我们在四例患者中诊断为 ARVC/D,在另外两例患者中诊断为 ARVC/D 的边界变异型。
ARVC/D 是一种具有多种复杂表现的心肌疾病。症状特征和检查及诊断程序的结果各不相同,并可能有多种组合。由于心电图、24 小时动态心电图和超声心动图等非侵入性和广泛使用的技术,大多数患者可以得到准确的诊断。(Cardiol J 2007; 14: 396-401)。